NOTE: the CIDG editorial base closed permanently on Thurs 19 Dec 2024.
Read our 2024 CIDG end of year and programme message.

News

Growth monitoring and promotion for children in LMICs: unclear and limited evidence
Once the mainstay of child health clinics in low- and middle-income countries (LMICs), a new Cochrane Review of growth monitoring and promotion (GMP) shows the evidence to support its use is limited and uncertain.
Highlights and experiences of the 2023 Cochrane Colloquium
The annual Cochrane Colloquium brings people together from around the world to discuss research into important global health questions and promote evidence-informed health care. The 2023 theme, ‘Forward together for trusted evidence’, explored the challenges for the future around trustworthiness of healthcare data and information whilst also celebrating 30 years of Cochrane producing trusted evidence.
New review: The impact of growth monitoring and promotion on health indicators in children under five years of age in low‐ and middle‐income countries
What is growth monitoring and promotion?
What's New! CIDG publications October 2023
During October 2023, the CIDG contributed to one new Cochrane Review in Issue 10, 2023 of the Cochrane Database of Systematic Reviews.New review
What's New! CIDG publications September 2023
During September 2023, the CIDG published one new Cochrane Protocol in Issue 9, 2023 of the Cochrane Database of Systematic Reviews.New Cochrane Protocol
What's New! CIDG publications August 2023
During August 2023, the CIDG published one new Cochrane Review in Issue 8, 2023 of the Cochrane Database of Systematic Reviews.New Cochrane Review
New review: Topical repellents for malaria prevention
What are the benefits and risks of using topical insect repellents to prevent malaria?Key messages• Topical repellents may slightly reduce the incidence and prevalence of malaria caused by Plasmodium falciparum.
What's New! CIDG publications July 2023
During July 2023, the CIDG published one new Cochrane Review  in Issue 7, 2023 of the Cochrane Database of Systematic Reviews.
Cochrane Colloquium London 4-6 September 2023
Cochrane Colloquium London 2023
New review: Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post-COVID-19 condition
Exhaustion, brain fog, and headaches are common in post-COVID-19 condition, sometimes called “long covid”. Social media and newspapers report the theory that this is caused by “microclots” which cause a shortage of oxygen to body tissues. This has led patients to seek expensive treatment through plasmapheresis, a procedure that takes blood out of the body and filters it.